Leading pharmaceutical outsourcing service provider grows its U.S. technology presence in Sorrento Mesa
SAN DIEGO, Calif. (June 26, 2019) — Irvine Company Office Properties today announced that PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, has leased a 38,000 square-foot building at Canyon Ridge Technology Park, an 11-building campus set in Sorrento Mesa.
PCI acquired San Diego-based Sherpa Clinical Packaging in 2018, which expanded PCI’s U.S. operations to the West Coast.
The new two-story state-of-the-art facility – located less than a mile from its existing San Diego campus – will serve as PCI’s main storage, logistics and distribution center on the West Coast. Beyond controlled room temperature, the building will be equipped for Cold Chain requirements for 2-8°C, -20°C, and -80°C with expanded ultra-low freezer capabilities, as well as cryogenic liquid nitrogen storage at -196°C.
“Cutting-edge companies like PCI Pharma Services are a great addition to the diverse lineup at Canyon Ridge Technology Park,” said John Turner, regional vice president, Irvine Company Office Properties. “We are always looking to provide today’s leading companies dynamic space to foster innovation and growth.”
As a long term owner who continually reinvests, Irvine Company has recently upgraded Canyon Ridge Technology Park’s amenities to elevate work-life balance, including outdoor collaborative workspaces, BBQ areas for team events, comfortable seating for dining and lounging, and on-site gourmet food trucks. The central location is minutes from UC San Diego, Scripps Institute and La Jolla UTC, providing easy access to freeways, and is close to Westfield UTC Mall, with more than 30 dining choices and luxury retail experiences.
“We are delighted to have worked with Irvine Company to secure our third site in San Diego. This latest facility enables us to continue to provide industry-leading reliability, flexibility and quality in clinical supply management services to our pharmaceutical and biopharmaceutical clients,” said Mark Shepanski, PCI executive director of operations and San Diego site leader. “As our customers experience continued success, we want to make sure we adapt and grow with them, supporting their needs for additional storage space for their larger Clinical studies.
“We have effectively positioned PCI in a highly-desirable property that is conveniently located near to outstanding amenities and housing options. We’re excited to be part of the vibrant community at Canyon Ridge Technology Park and look forward to taking forward our strategic growth plans in this location over the years to come.”
Sorrento Mesa is San Diego’s fastest growing tech hub, home to companies that include Qualcomm, Texas Instruments, T-Mobile, Novatel Wireless, and NuVasive providing a deep pool for experienced engineering talent.
Irvine Company owns nine million square feet of San Diego office workplace communities in Downtown, Del Mar Heights, La Jolla UTC, Mission Valley, and Sorrento Mesa.
About Irvine Company Office Properties
As a long-term owner who continuously reinvests in its properties and services, Irvine Company has evolved the traditional office to something much more: vibrant workplace communities. A place where collaboration is encouraged, and creativity is enabled to elevate business success. The company serves more than 3,000 customers in 50 million square feet of premier workplace communities in Orange County, Los Angeles, Silicon Valley and San Diego, as well as iconic trophy towers in Chicago and New York. Timeless design and quality craftsmanship is paired with Irvine Company’s permanent time horizon, customer-centric brand and pride of ownership.
The global healthcare industry trusts PCI for the development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over five decades in the healthcare business. Leading technology and continued investment enables us to address global needs throughout the product life cycle — from preclinical development, clinical investigational studies, commercialization and ongoing supply. Our customers view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives.